Boston and Cambridge host one of the most concentrated biotech and life sciences venture ecosystems in the world, anchored by proximity to MIT, Harvard, and a dense cluster of teaching hospitals - several of the firms below were built specifically to commercialize research coming directly out of that academic corridor.
Cambridge, MA
Founded 2000
Snap's 2017 IPO, one of the largest consumer tech listings of its era
HealthcareFintechAI Infrastructure
View Full Firm Profile →
$19B invested cumulatively across funds (not a current single fund figure)
Assets Managed
Alnylam Pharmaceuticals' 2004 IPO (NASDAQ: ALNY) - an early Polaris healthcare investment
HealthcareEnterprise Software
View Full Firm Profile →
$14.4B (2025)
Assets Managed
No single defined public exit documented - RA Capital invests across biotech, pharma, diagnostics, and digital health
Healthcare
View Full Firm Profile →
Wayfair's 2014 IPO - Battery led the company's first institutional financing round in 2011, after General Partner Neeraj Agrawal recognized the opportunity through a decade-long friendship with co-founder Niraj Shah
Enterprise SoftwareSaaSConsumer InternetIndustrial Technology
View Full Firm Profile →
Amazon's 2012 acquisition of Kiva Systems - Ajay Agarwal led BCV's first institutional round in the warehouse robotics startup in 2004, and its technology now powers Amazon Robotics across more than 2,000 fulfillment cen…
Enterprise SoftwareFintechSaaSCybersecurity
View Full Firm Profile →
Twitter's 2013 IPO - Spark led the company's early investment in 2007 when it had fewer than a dozen employees
Consumer InternetEnterprise SoftwareFintechAI
View Full Firm Profile →
Cambridge, MA
Founded 1970
Beam Therapeutics' 2020 Nasdaq IPO - President Stephen Knight personally co-founded the gene-editing company and has served on its board since 2017
BiotechHealthcareEnterprise SoftwareFintech
View Full Firm Profile →
$3.8B (raised since inception)
Assets Managed
Bluebird Bio's public listing - one of the category-defining gene and cell therapy companies Third Rock built from early scientific concept through IPO, alongside Agios Pharmaceuticals and Foundation Medicine
BiotechTherapeuticsLife Sciences
View Full Firm Profile →
Cambridge, MA
Founded 2000
$3.4B (single fund, 2021); has raised multiple funds since 2000
Assets Managed
Moderna's December 2018 Nasdaq IPO, which raised approximately $604 million at a roughly $7.5 billion valuation - one of the largest biotech IPOs ever at the time, years before Moderna became a household name during the …
BiotechHealthcareClimateLife Sciences
View Full Firm Profile →
Cambridge, MA
Founded 1980
Akero Therapeutics' $4.7 billion acquisition by Novo Nordisk in 2025, expanding its MASH treatment portfolio - one of Atlas's clearest recent wins, alongside Nimbus Therapeutics' $4 billion TYK2 licensing deal with Taked…
HealthcareDeep Tech
View Full Firm Profile →
$2.4B (across seven funds)
Assets Managed
Datadog's independent NASDAQ IPO at a $7.83 billion market cap, and Expensify's NASDAQ IPO in November 2021 at a $1.82 billion market cap - OpenView's two confirmed public listings among more than 60 portfolio companies
Enterprise SoftwareFintechAI
View Full Firm Profile →
Over $2.4B (assets under management as of 30 September 2025, as stated in the Helix Acquisition Corp. III IPO prospectus, Form 424B4 filed 23 January 2026; the firm's Form ADV Item 5.F figure could not be read)
Assets Managed
BiotechLife SciencesHealthcareMedtech
View Full Firm Profile →
$1B (assets under management, per flybridge.com homepage)
Assets Managed
MongoDB (IPO, 2017)
AIDeveloper ToolsEnterprise SoftwareSaaS
View Full Firm Profile →
Over $1B (of investment capital under management, per the firm's own boilerplate of 16 November 2022; no more recent firm-stated figure was found, and this excludes parent MassMutual's own assets)
Assets Managed
Recorded Future (acquired by Insight Partners, as stated on MassMutual Ventures' own bio for Mark Goodman)
Enterprise SoftwareSaaSClimate TechnologyFintech
View Full Firm Profile →
Portfolio company Nauticus Robotics went public on Nasdaq in September 2022 through a SPAC merger with CleanTech Acquisition Corp, with Material Impact remaining a major shareholder.
Deep TechHard TechAdvanced ManufacturingRobotics
View Full Firm Profile →
Cambridge, MA
Founded 1977
Oculus VR's 2014 acquisition by Facebook for approximately $2.3 billion - Matrix backed the company at an early stage
AIInfrastructureFintechSemiconductors
View Full Firm Profile →
$405M (final fund, closed 2022 per Axios; firm-wide AUM not publicly disclosed)
Assets Managed
DraftKings (went public via SPAC merger, 2020)
CybersecurityEnterprise SoftwareConsumerFintech
View Full Firm Profile →
ThredUp's 2021 Nasdaq IPO - NextView backed the online consignment marketplace as a seed-stage investor years before its public debut
MarketplacesConsumerDigital HealthVertical SaaS
View Full Firm Profile →
Cambridge, MA
Founded 2009
$95M+ (latest fund)
Assets Managed
PillPack's 2018 acquisition by Amazon for approximately $1 billion - Founder Collective was among the pharmacy startup's first seed investors
Seed-StageSector-Agnostic
View Full Firm Profile →
$50M (Fund I target at 2022 launch, $25M committed)
Assets Managed
No confirmed public exit yet; the firm's notable positions remain private.
RoboticsIndustrial TechAILogistics
View Full Firm Profile →
Not publicly disclosed (no AUM figure is published; the Form D figures are $16.3M sold on a $50M Fund I offering, $56.4M sold on Fund II, and $31.35M sold on a $60M Fund III as at January 2026 - offering and sold figures, not AUM, and not summed)
Assets Managed
AI/MLSaaSFintechDeep Tech
View Full Firm Profile →
Cambridge, MA
Founded 2016
$1.1 billion
Assets Managed
No confirmed public exit yet; the firm's notable positions remain private.
Deep TechHard TechClimateEnergy
View Full Firm Profile →
Not publicly disclosed
Assets Managed
Machine IntelligenceData ScienceDistributed SystemsAutomation
View Full Firm Profile →